These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8277177)

  • 1. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections.
    van Deuren M; van der Ven-Jongekrijg J; Demacker PN; Bartelink AK; van Dalen R; Sauerwein RW; Gallati H; Vannice JL; van der Meer JW
    J Infect Dis; 1994 Jan; 169(1):157-61. PubMed ID: 8277177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run.
    Drenth JP; Krebbers RJ; Bijzet J; van der Meer JW
    Eur J Clin Invest; 1998 Oct; 28(10):866-72. PubMed ID: 9793002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production.
    Drenth JP; Van Uum SH; Van Deuren M; Pesman GJ; Van der Ven-Jongekrijg J; Van der Meer JW
    J Appl Physiol (1985); 1995 Nov; 79(5):1497-503. PubMed ID: 8594005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.
    Drenth JP; van Deuren M; van der Ven-Jongekrijg J; Schalkwijk CG; van der Meer JW
    Blood; 1995 Jun; 85(12):3586-93. PubMed ID: 7780142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
    Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
    J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection.
    Vogels MT; Mensink EJ; Ye K; Boerman OC; Verschueren CM; Dinarello CA; van der Meer JW
    J Immunol; 1994 Dec; 153(12):5772-80. PubMed ID: 7989774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharide from Actinobacillus actinomycetemcomitans stimulates production of interleukin-1beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-1 receptor antagonist in human whole blood.
    Schytte Blix IJ; Helgeland K; Hvattum E; Lyberg T
    J Periodontal Res; 1999 Jan; 34(1):34-40. PubMed ID: 10086884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections.
    van Deuren M; van der Ven-Jongekrijg J; Vannier E; van Dalen R; Pesman G; Bartelink AK; Dinarello CA; van der Meer JW
    Blood; 1997 Aug; 90(3):1101-8. PubMed ID: 9242541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF receptor.
    Karkar AM; Tam FW; Steinkasserer A; Kurrle R; Langner K; Scallon BJ; Meager A; Rees AJ
    Kidney Int; 1995 Dec; 48(6):1738-46. PubMed ID: 8587234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
    J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1, TNF alpha and their naturally occurring antagonists in sepsis.
    Moldawer LL
    Blood Purif; 1993; 11(2):128-33. PubMed ID: 8274244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections.
    van Deuren M; van der Ven-Jongekrijg J; Bartelink AK; van Dalen R; Sauerwein RW; van der Meer JW
    J Infect Dis; 1995 Aug; 172(2):433-9. PubMed ID: 7622886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections.
    van Deuren M
    Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 1():S12-6. PubMed ID: 7821299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating and ex vivo production of pyrogenic cytokines and interleukin-1 receptor antagonist in 123 patients with fever of unknown origin. The Netherlands Fever of Unknown Origin Study Group.
    de Kleijn EM; Drenth JP; Pesman GJ; van Druten H; Demacker PN; van der Meer JW
    J Infect Dis; 1997 Jan; 175(1):191-5. PubMed ID: 8985219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns.
    Sikora JP; Chlebna-Sokół D; Dabrowska I; Lipczyński D; Chrul S
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):155-61. PubMed ID: 11348020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 1 beta, tumour necrosis factor-alpha and interleukin 1 receptor antagonist in newly diagnosed insulin-dependent diabetes mellitus: comparison to long-standing diabetes and healthy individuals.
    Netea MG; Hancu N; Blok WL; Grigorescu-Sido P; Popa L; Popa V; van der Meer JW
    Cytokine; 1997 Apr; 9(4):284-7. PubMed ID: 9112337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.
    Bemelmans MH; Gouma DJ; Buurman WA
    J Immunol; 1993 Nov; 151(10):5554-62. PubMed ID: 8228246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttranscriptional down-regulation of tumor necrosis factor-alpha and interleukin-1beta production in acute meningococcal infections.
    van Deuren M; Netea MG; Hijmans A; Demacker PN; Neeleman C; Sauerwein RW; Bartelink AK; van der Meer JW
    J Infect Dis; 1998 May; 177(5):1401-5. PubMed ID: 9593034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour necrosis factor soluble receptors I and II and interleukin-1 receptor antagonist in acute pyelonephritis in relation to bacterial virulence-associated traits and renal function.
    Jacobson SH; Lu Y; Brauner A
    Nephrol Dial Transplant; 1996 Nov; 11(11):2209-14. PubMed ID: 8941580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.